Pyrimethamine |
Daraprim |
Pyrimethamine Systematic (IUPAC) name 5-(4-chlorophenyl)-6-ethyl-2,4-pyrimidinediamine Identifiers CAS number 58-14-0 ATC code P01BD01 PubChem 4993 DrugBank APRD00599 Chemical data Formula C12H13N4Cl Mol. weight 248.71 g/mol Pharmacokinetic data Bioavailability well-absorbed Metabolism ? Half life 96 hours Excretion ? Therapeutic considerations Pregnancy cat. C: (USA) ?: (AUS) Legal status Prescription only Routes Oral Pyr ...
Wikipedia - [full article]
Pyrimethamine Clinical Trials
- The Effect of Folic Acid on Efficacy of Sulfadoxine-Pyrimethamine in Pregnant Women in Western Kenya
ClinicalTrials.gov Identifier: NCT00130065 - Active, not recruiting
Malaria
- Efficacy of Sulphadoxine-Pyrimethamine and Artemisinin-Containing Combination Therapy for Malaria
ClinicalTrials.gov Identifier: NCT00140361 - Recruiting
Malaria (Uncomplicated)
- Efficacy Trial of Gestational Sulfadoxine-Pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth
ClinicalTrials.gov Identifier: NCT00131235 - Active, not recruiting
Malaria in pregnancy; Sexually Transmitted Diseases; Preterm Birth
- Navrongo Drug Options for IPT in Pregnancy Trial
ClinicalTrials.gov Identifier: NCT00146783 - Recruiting
Malaria
- Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
ClinicalTrials.gov Identifier: NCT00004317 - Recruiting
Toxoplasmosis
- Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-Pyrimethamine Intermittent Presumptive Treatment in Pregnant Women
ClinicalTrials.gov Identifier: NCT00380146 - Active, not recruiting
Malaria
- Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Infants
ClinicalTrials.gov Identifier: NCT00206739 - Active, not recruiting
Malaria; Anemia
- Artesunate Plus Sulfadoxine-Pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria
ClinicalTrials.gov Identifier: NCT00331708 - Active, not recruiting
Malaria
- Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: Malawi
ClinicalTrials.gov Identifier: NCT00126906 - Completed
Malaria, Falciparum; HIV Infections
- Longitudinal Antimalarial Combinations in Uganda
ClinicalTrials.gov Identifier: NCT00123552 - Active, not recruiting
Malaria
- ANTIMALARIAL DRUG RESISTANCE IN MALI
ClinicalTrials.gov Identifier: NCT00127998 - Completed
Malaria; Plasmodium falciparum
- Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
ClinicalTrials.gov Identifier: NCT00510159 - Recruiting
Schistosoma Haematobium
- Intermittent Preventative Treatment with Sulfadoxine-Pyrimethamine in Gambian Multigravidae
ClinicalTrials.gov Identifier: NCT00120809 - Completed
Malaria
- Intermittent Preventive Treatment with Antimalarials in Kenyan Infants
ClinicalTrials.gov Identifier: NCT00111163 - Active, not recruiting
Malaria; Anemia
- Preventing Malaria During Pregnancy in Epidemic-Prone Areas.
ClinicalTrials.gov Identifier: NCT00142207 - Active, not recruiting
Malaria, Falciparum
- IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.
ClinicalTrials.gov Identifier: NCT00361114 - Recruiting
Malaria
- Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines
ClinicalTrials.gov Identifier: NCT00229775 - Recruiting
Malaria
- The Efficacy of Re-Treatment with Sulfadoxine-Pyrimethamine in Children.
ClinicalTrials.gov Identifier: NCT00137553 - Completed
Malaria, Falciparum
- Efficacy and Safety of Sulphadoxine-Pyrimethamine and Amodiaquine in Ghanaian Pregnant Women.
ClinicalTrials.gov Identifier: NCT00131703 - Completed
Malaria in pregnancy
- Anti-Malarial Drug Resistance in Cameroon
ClinicalTrials.gov Identifier: NCT00146718 - Completed
Malaria
- A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma gondii Infection
ClinicalTrials.gov Identifier: NCT00000666 - Completed
Toxoplasmosis, Cerebral; HIV Infections
- Kilimanjaro IPTi Drug Options Trial
ClinicalTrials.gov Identifier: NCT00158574 - Recruiting
Malaria
- A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
ClinicalTrials.gov Identifier: NCT00000973 - Completed
Toxoplasmosis, Cerebral; HIV Infections
- A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
ClinicalTrials.gov Identifier: NCT00000674 - Completed
Toxoplasmosis, Cerebral; HIV Infections
- Effectiveness of Intermittent Preventive Treatment for Malaria in Children
ClinicalTrials.gov Identifier: NCT00119132 - Recruiting
Malaria
- A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients with AIDS
ClinicalTrials.gov Identifier: NCT00000966 - Completed
Toxoplasmosis, Cerebral; HIV Infections
- CQSP in Malawi: Chloroquine and Sulfadoxine-Pyrimethamine Efficacy for the Treatment of Malaria in Malawi.
ClinicalTrials.gov Identifier: NCT00125489 - Completed
Malaria
- The Community Effectiveness of IPTi in Southern Tanzania
ClinicalTrials.gov Identifier: NCT00152204 - Recruiting
Malaria, Falciparum; Anemia
- Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia
ClinicalTrials.gov Identifier: NCT00399074 - Recruiting
Sickle Cell Anemia; Malaria
- Kidney Transplants in People with HIV Infection
ClinicalTrials.gov Identifier: NCT00023478 - Active, not recruiting
HIV Infections; End-Stage Renal Disease
- Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
ClinicalTrials.gov Identifier: NCT00000794 - Completed
Toxoplasmosis, Cerebral; HIV Infections
- A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)
ClinicalTrials.gov Identifier: NCT00000727 - Completed
Pneumonia, Pneumocystis carinii; HIV Infections
- Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children
ClinicalTrials.gov Identifier: NCT00118807 - Completed
Malaria
- Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India
ClinicalTrials.gov Identifier: NCT00074841 - Completed
Plasmodium falciparum Malaria
- Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
ClinicalTrials.gov Identifier: NCT00065390 - Completed
Autoimmune Disease; Lymphatic Disease; Lymphoproliferative Disorder
- Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine
ClinicalTrials.gov Identifier: NCT00167739 - Completed
Malaria
- Prevention of Severe Anaemia in Gambian Children
ClinicalTrials.gov Identifier: NCT00131716 - Completed
Anaemia
- A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children.
ClinicalTrials.gov Identifier: NCT00132548 - Completed
Malaria
- Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria
ClinicalTrials.gov Identifier: NCT00486694 - Completed
Malaria, Vivax
- A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children.
ClinicalTrials.gov Identifier: NCT00132561 - Completed
Malaria
- Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Jakarta, Indonesia
ClinicalTrials.gov Identifier: NCT00084240 - Terminated
Plasmodium falciparum Malaria
- A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda
ClinicalTrials.gov Identifier: NCT00118027 - Completed
Malaria; Pregnancy; Anemia
- In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults
ClinicalTrials.gov Identifier: NCT00144352 - Completed
Malaria; HIV; AIDS
- Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse
ClinicalTrials.gov Identifier: NCT00002064 - Completed
Toxoplasmosis, Cerebral; HIV Infections
- To Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, Indonesia
ClinicalTrials.gov Identifier: NCT00157859 - Completed
Falciparum Malaria; Vivax Malaria
- A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or are Intolerant of Pyrimethamine-Sulfadiazine
ClinicalTrials.gov Identifier: NCT00001994 - Completed
Toxoplasmosis, Cerebral; HIV Infections
- Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
ClinicalTrials.gov Identifier: NCT00140517 - Completed
Malaria in pregnancy; Birth Weight; Anaemia
- Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda
ClinicalTrials.gov Identifier: NCT00132535 - Completed
Malaria in pregnancy; Birth Weight; Anaemia
- Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00000643 - Completed
Toxoplasmosis, Cerebral; HIV Infections
- ACT with Chloroquine, Amodiaquine & Sulphadoxine-Pyrimethamine in Pakistan
ClinicalTrials.gov Identifier: NCT00158548 - Completed
Malaria; Falciparum Malaria; Vivax Malaria
- Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome
ClinicalTrials.gov Identifier: NCT00013689 - Completed
Autoimmune Disease; Lymphoproliferative Disorder
- Chlorproguanil/Dapsone Compared with Chloroquine and SP for Vivax Malaria
ClinicalTrials.gov Identifier: NCT00158561 - Completed
Malaria; Vivax Malaria
- Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children
ClinicalTrials.gov Identifier: NCT00453856 - Terminated
Malaria

Not Signed In -


